Benitec Biopharma Inc. (BNTC)
NASDAQ · Healthcare
Benitec Biopharma Inc. EBITDA 2019–2024
Benitec Biopharma Inc. annual/quarterly ebitda history and growth rate from 2019 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Benitec Biopharma Inc. ebitda for the quarter ending March 31, 2026 was -13.6 M, a 11.45% decrease year-over-year.
- Benitec Biopharma Inc. ebitda for the twelve months ending March 31, 2026 was -52.0 M, a 88.68% increase year-over-year.
- Benitec Biopharma Inc. annual ebitda for 2024 was -22.4 M, a 18.25% increase from 2023.
- Benitec Biopharma Inc. annual ebitda for 2023 was -18.9 M, a 7.11% increase from 2022.
- Benitec Biopharma Inc. annual ebitda for 2022 was -17.7 M, a 32.34% increase from 2021.
- Benitec Biopharma Inc. annual ebitda for 2021 was -13.4 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Benitec Biopharma Inc. EBITDA — FAQ
Benitec Biopharma Inc. (BNTC) ebitda over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BNTC's ebitda history?
The chart and table above show Benitec Biopharma Inc.'s ebitda by year and by quarter, including the growth rate.